Driving the intersection of science and technology to transform neurobehavioral health
BlackThorn Therapeutics is a computational sciences company with capabilities to develop proprietary therapeutics focused on neurobehavioral disorders. We have pioneered the development of a computational psychiatry platform to advance our robust pipeline of novel therapeutics. We leverage data-driven approaches to solve the patient selection problem to create treatments that improve patient outcomes.
Our drug discovery and development approach builds upon recent advances and insights we have generated in understanding neurobehavioral disorders through a circuit-based approach vs. the historical categorical approach. By viewing neurobehavioral disorders in this new construct, we believe we can more successfully advance targeted therapeutics. We have a deep pipeline of best-in-class and first-in-class molecules targeting key neurobehavioral health needs.